The Incidence of New Persistent Opioid Use Following Cardiac Surgery via Sternotomy.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsIngason, Arnar B
Muehlschlegel, Jochen D
Sigurdsson, Martin I
MetadataShow full item record
CitationIngason AB, Geirsson A, Gudbjartsson T, Muehlschlegel JD, Sigurdsson MI. The Incidence of New Persistent Opioid Use Following Cardiac Surgery via Sternotomy. Ann Thorac Surg. 2022;113(1):33-40. doi:10.1016/j.athoracsur.2021.04.030
AbstractBackground: In recent years, increased attention has turned toward the risk of chronic opioid use after surgery. In this nationwide cohort study, we examined the rate of new persistent opioid use after cardiac surgery by sternotomy. Methods: All opioid-naive patients undergoing heart surgery by sternotomy from 2005 to 2018 in Iceland were included in the study. Naivety was defined as not filling an opioid prescription within 6 months before surgery. Persistent opioid use was defined as filling at least 1 opioid prescription during the first 90 days after surgery and another 90 to 180 days after the operation. In addition to estimating the incidence of new persistent opioid use, differences in patient characteristics, survival, and readmission rates were compared between the group with and without new persistent opioid use. Results: Of 1227 patients who underwent cardiac surgery by sternotomy during the study period, 925 were included in the study. Of those, 4.6% developed new persistent opioid use. When only patients who filled an opioid prescription after surgery were included, 10.1% developed new persistent opioid use. Chronic obstructive pulmonary disease, preoperative use of nonsteroidal anti-inflammatory drugs, gabapentinoids, and nitrates were associated with increased risk for new persistent opioid use. Patients with new persistent opioid use did not have higher rates of readmission nor all-cause mortality. Conclusions: The rate of new persistent opioid use after cardiac surgery was 4.6%. Future steps should identify strategies to minimize the development of new persistent opioid use.
DescriptionTo access publisher's full text version of this article click on the hyperlink below
RightsCopyright © 2022 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
- Persistent Opioid Use after Ophthalmic Surgery in Opioid-Naive Patients and Associated Risk Factors.
- Authors: Ung C, Yonekawa Y, Waljee JF, Gunaseelan V, Lai YL, Woodward MA
- Issue date: 2021 Sep
- Persistent pain after cardiac surgery: an audit of high thoracic epidural and primary opioid analgesia therapies.
- Authors: Ho SC, Royse CF, Royse AG, Penberthy A, McRae R
- Issue date: 2002 Oct
- Development of Persistent Opioid Use After Cardiac Surgery.
- Authors: Brown CR, Chen Z, Khurshan F, Groeneveld PW, Desai ND
- Issue date: 2020 Aug 1
- New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults.
- Authors: Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, Bohnert ASB, Kheterpal S, Nallamothu BK
- Issue date: 2017 Jun 21
- Association Between Preoperative Opioid and Benzodiazepine Prescription Patterns and Mortality After Noncardiac Surgery.
- Authors: Sigurdsson MI, Helgadottir S, Long TE, Helgason D, Waldron NH, Palsson R, Indridason OS, Gudmundsdottir IJ, Gudbjartsson T, Sigurdsson GH
- Issue date: 2019 Aug 1